We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$4.36B
AUM Growth
+$1.42B
Cap. Flow
+$2.09B
Cap. Flow %
47.88%
Top 10 Hldgs %
44.57%
Holding
147
New
40
Increased
52
Reduced
12
Closed
36

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$86.1M
2
TJX icon
TJX Companies
TJX
+$75.5M
3
TVTX icon
Travere Therapeutics
TVTX
+$65.1M
4
AMZN icon
Amazon
AMZN
+$63.1M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$52.3M

Top Sells

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$45.4M
2
ORLY icon
O'Reilly Automotive
ORLY
+$41M
3
ULTA icon
Ulta Beauty
ULTA
+$39.7M
4
FIVE icon
Five Below
FIVE
+$38M
5
FTDR icon
Frontdoor
FTDR
+$32.9M

Sector Composition

Rank Sector Weight
1 Healthcare 46.59%
2 Consumer Staples 10.1%
3 Consumer Discretionary 9.65%
4 Technology 2.31%
5 Industrials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSCO icon
51
Tractor Supply
TSCO
$17.4B
$23.5M 0.54%
+663,685
New +$21.2M
BIO icon
52
Bio-Rad Laboratories Class A
BIO
$9.17B
$21.7M 0.5%
38,000
+5,000
+15% +$2.96M
LW icon
53
Lamb Weston
LW
$7.32B
$21.5M 0.49%
+278,000
New +$21.9M
KOF icon
54
Coca-Cola Femsa
KOF
$23.2B
$20.1M 0.46%
+436,000
New +$20M
POST icon
55
Post Holdings
POST
$4.08B
$19.9M 0.46%
287,264
+18,336
+7% +$1.2M
UBER icon
56
Uber
UBER
$137B
$19.6M 0.45%
360,000
+180,000
+100% +$10M
CRSP icon
57
CRISPR Therapeutics
CRSP
$5.18B
$19M 0.44%
156,000
+84,000
+117% +$12.7M
CL icon
58
Colgate-Palmolive
CL
$73.7B
$18.6M 0.43%
+236,000
New +$18.5M
ADMS
59
DELISTED
Adamas Pharmaceuticals
ADMS
$18.5M 0.43%
3,856,000
+1,114,000
+41% +$5.82M
ILMN icon
60
Illumina
ILMN
$30.4B
$18.4M 0.42%
49,344
-2,056
-4% -$838K
AVTR icon
61
Avantor
AVTR
$9.11B
$18.4M 0.42%
636,000
+88,000
+16% +$2.54M
TWNK
62
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$18.3M 0.42%
1,278,000
-300,000
-19% -$4.4M
VYGR icon
63
Voyager Therapeutics
VYGR
$188M
$17.5M 0.4%
3,716,000
+324,000
+10% +$2.21M
KPRX icon
64
Kiora Pharmaceuticals
KPRX
$11M
$16.7M 0.38%
9,296
+4,253
+84% +$9.27M
FREE
65
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$15.6M 0.36%
1,200,000
+92,000
+8% +$1.17M
GAP
66
The Gap Inc
GAP
$7.43B
$15.4M 0.35%
+515,617
New +$12.8M
FIVE icon
67
Five Below
FIVE
$12.3B
$12.7M 0.29%
66,800
-201,385
-75% -$38M
POOL icon
68
Pool Corp
POOL
$7.45B
$12.7M 0.29%
+36,875
New +$12.8M
UAA icon
69
Under Armour
UAA
$2.91B
$12.6M 0.29%
+566,881
New +$11.8M
BIOR
70
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$12.5M 0.29%
+10,490
New +$14.5M
SIBN icon
71
SI-BONE Inc
SIBN
$795M
$11.6M 0.27%
364,000
+40,000
+12% +$1.23M
AEO icon
72
American Eagle Outfitters
AEO
$3.01B
$11.3M 0.26%
+387,995
New +$9.93M
ADV icon
73
Advantage Solutions
ADV
$417M
$10.6M 0.24%
+36,000
New +$9.59M
ASMB icon
74
Assembly Biosciences
ASMB
$528M
$10.3M 0.24%
186,333
-32,334
-15% -$2.14M
LULU icon
75
lululemon athletica
LULU
$14B
$10.2M 0.24%
+33,373
New +$11M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Armistice Capital held 147 positions worth $4.36B, up 48% from $2.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Armistice Capital deployed $2.09B of net new capital in Q1 2021, opening 40 new positions and adding to 52 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 392,000 shares worth $84.2M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Lantheus, an estimated $45.4M trimmed.

  • Armistice Capital's largest Q1 2021 buy was Vertex Pharmaceuticals: 392,000 shares worth $84.2M.
  • Armistice Capital added most to Amazon in Q1 2021, an estimated $63.1M increase.
  • Armistice Capital's biggest Q1 2021 reduction was Lantheus, cutting an estimated $45.4M.
  • Armistice Capital fully exited O'Reilly Automotive in Q1 2021, selling an estimated $41M.
  • Armistice Capital's ten largest holdings make up 45% of its $4.36B portfolio in Q1 2021.
  • Armistice Capital opened 40 new positions and closed 36 in Q1 2021.
  • Armistice Capital's portfolio value rose 48% quarter-over-quarter to $4.36B.

Based on Armistice Capital's 13F filing for Q1 2021, filed 17 May 2021.